EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MNKD
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

MannKind Corporation stock upgraded to Buy Candidate.
(Updated on Jun 25, 2024)

Buy or Hold candidate since Jun 11, 2024 Gain 12.69% PDF

The MannKind Corporation stock price fell by -3.50% on the last day (Tuesday, 25th Jun 2024) from $5.43 to $5.24. During the last trading day the stock fluctuated 5.42% from a day low at $5.23 to a day high of $5.51. The price has risen in 7 of the last 10 days and is up by 16.7% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 million shares and in total, 3 million shares were bought and sold for approximately $14.62 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.14% during the next 3 months and, with a 90% probability hold a price between $5.22 and $6.21 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MNKD Signals & Forecast

The MannKind Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.00 and $4.68. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 24, 2024, and so far it has fallen -3.50%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for MannKind Corporation stock

MannKind Corporation finds support from accumulated volume at $5.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.283 between high and low, or 5.42%. For the last week, the stock has had daily average volatility of 5.39%.

Our recommended stop-loss: $4.94 (-5.64%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 48 days ago.)

Trading Expectations (MNKD) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect MannKind Corporation to open at $5.32, and during the day (based on 14 day Average True Range), to move between $5.01 and $5.47, which gives a possible trading interval of +/-$0.232 (+/-4.43%) up or down from last closing price. If MannKind Corporation takes out the full calculated possible swing range there will be an estimated 8.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.11 (2.48%) than the resistance at $5.43 (3.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MannKind Corporation stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for MannKind Corporation stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.259 Buy Candidate Upgraded

Predicted Opening Price for MannKind Corporation of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
$5.32 ( 1.61%) $5.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MNKD

Fibonacci Support & Resistance Levels

Level Price
R3 5.61 7.02%
R2 5.50 4.95%
R1 5.43 3.68%
Price 5.24
S1 5.22 -0.454%
S2 5.15 -1.73%
S3 5.04 -3.80%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 5.43 3.63%
Price 5.24
S1 5.11 -2.48%
S2 4.63 -11.64%
S3 4.31 -17.75%

FAQ

What is the symbol for MannKind Corporation Stock and on which exchange is it traded?
The symbol for MannKind Corporation is MNKD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MannKind Corporation Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for MannKind Corporation stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy MannKind Corporation Stock?
MannKind Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MannKind Corporation Stock.

What's the current price of MannKind Corporation Stock?
As of the end of day on the Jun 25, 2024, the price of an MannKind Corporation (MNKD) share was $5.24.

What is the 52-week high and low for MannKind Corporation Stock?
The 52-week high for MannKind Corporation Stock is $5.75 and the 52-week low is $3.17.

What is the market capitalization of MannKind Corporation Stock?
As of the Jun 25, 2024, the market capitalization of MannKind Corporation is 1.479B.

When is the next earnings date for MannKind Corporation?
The upcoming earnings date for MannKind Corporation is Aug 05, 2024.
Click to get the best stock tips daily for free!

About MannKind Corporation

MannKind MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a licens... MNKD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT